|
[1]
|
Siegel, R.L., Miller, K.D., Fuchs, H.E., et al. (2022) Cancer Statistics, 2022. CA: A Cancer Journal for Clinicians, 72, 7-33. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Gao, S., Chen, T., Li, L., et al. (2020) Hypoxia-Inducible Ubiquitin Specific Peptidase 13 Contributes to Tumor Growth and Metastasis via Enhancing the Toll-Like Receptor 4/Myeloid Differentiation Primary Response Gene 88/Nuclear Factor-κB Pathway in Hepatocellular Carcinoma. Frontiers in Cell and Developmental Biology, 8, Article 587389. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Cheung, T.T., Dai, W.C., Tsang, S.H., et al. (2016) Pure Laparoscopic Hepatectomy versus Open Hepatectomy for Hepatocellular Carcino-ma in 110 Patients with Liver Cirrhosis: A Propensity Analysis at a Single Center. Annals of Surgery, 264, 612-620. [Google Scholar] [CrossRef]
|
|
[4]
|
Belli, G., Limongelli, P., Fantini, C., et al. (2009) Laparo-scopic and Open Treatment of Hepatocellular Carcinoma in Patients with Cirrhosis. British Journal of Surgery, 96, 1041-1048. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
马逸云, 蒋华, 张宏亨. 腹腔镜肝切除术与开腹肝切除术治疗肝硬化肝细胞癌患者的效果比较[J]. 临床肝胆病杂志, 2016, 32(10): 1916-1919.
|
|
[6]
|
Memeo, R., De’Angelis, N., Compagnon, P., et al. (2014) Laparoscopic vs. Open Liver Resection for Hepatocellular Carcinoma of Cirrhotic Liver: A Case-Control Study. World Journal of Surgery, 38, 2919-2926. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Cupp, M.A., Cariolou, M., Tzoulaki, I., et al. (2020) Neutrophil to Lymphocyte Ratio and Cancer Prognosis: An Umbrella Review of Systematic Reviews and Meta-Analyses of Observa-tional Studies. BMC Medicine, 18, Article No. 360. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
王明弘, 江斌, 王健, 等. 系统免疫炎症指数与肝细胞癌切除术后预后相关性分析[J]. 腹部外科, 2022, 35(1): 31-36, 46.
|
|
[9]
|
Muller, L., Hahn, F., Mahringer-Kunz, A., et al. (2021) Immunonutritive Scoring for Patients with Hepatocel-lular Carcinoma Undergoing Transarterial Chemoembolization: Evaluation of the CALLY Index. Cancers, 13, Article 5018. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Balkwill, F. and Mantovani, A. (2001) Inflammation and Cancer: Back to Virchow? Lancet, 357, 539-545. [Google Scholar] [CrossRef]
|
|
[11]
|
Hanahan, D. (2022) Hallmarks of Cancer: New Dimensions. Cancer Discovery, 12, 31-46. [Google Scholar] [CrossRef]
|
|
[12]
|
Ocana, A., Nieto-Jimenez, C., Pandiella, A., et al. (2017) Neutrophils in Cancer: Prognostic Role and Therapeutic Strategies. Molecular Cancer, 16, Article No. 137. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Coffelt, S.B., Wellenstein, M.D. and De Visser, K.E. (2016) Neu-trophils in Cancer: Neutral No More. Nature Reviews Cancer, 16, 431-446. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Jaillon, S., Ponzetta, A., Di Mitri, D., et al. (2020) Neutrophil Diversity and Plasticity in Tumour Progression and Therapy. Nature Reviews Cancer, 20, 485-503. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Gao, L., Zhang, H., Zhang, B., et al. (2017) Prognostic Value of Combination of Preoperative Platelet Count and Mean Platelet Volume in Patients with Resectable Non-Small Cell Lung Cancer. Oncotarget, 8, 15632-15641. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Palacios-Acedo, A.L., Langiu, M., Crescence, L., et al. (2022) Platelet and Cancer-Cell Interactions Modulate Cancer-Associated Thrombosis Risk in Different Cancer Types. Cancers, 14, Article 730. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Wang, Y., Yang, X., Yu, Y., et al. (2018) Immunotherapy of Patient with Hepatocellular Carcinoma Using Cytotoxic T Lymphocytes ex Vivo Activated with Tumor Antigen-Pulsed Dendritic Cells. Journal of Cancer, 9, 275-287. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Hu, B., Yang, X.R., Xu, Y., et al. (2014) Systemic Immune-Inflammation Index Predicts Prognosis of Patients after Curative Resection for Hepatocellular Carcinoma. Clinical Cancer Research, 20, 6212-6222. [Google Scholar] [CrossRef]
|
|
[19]
|
刘霄, 唐菁, 李笃军. C-反应蛋白在肿瘤发生发展中的作用[J]. 生命的化学, 2011, 31(6): 868-870.
|
|
[20]
|
Gupta, D. and Lis, C.G. (2010) Pretreatment Serum Albumin as a Predictor of Cancer Survival: A Systematic Review of the Epidemiological Literature. Nutrition Journal, 9, Article No. 69. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Iida, H., Tani, M., Komeda, K., et al. (2022) Superiority of CRP-Albumin-Lymphocyte Index (CALLY Index) as a Non-Invasive Prognostic Biomarker after Hepatectomy for Hepatocellular Carcinoma. HPB, 24, 101-115. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Wang, W., Gu, J., Liu, Y., et al. (2022) Pre-Treatment CRP-Albumin-Lymphocyte Index (CALLY Index) as a Prognostic Biomarker of Survival in Patients with Epithelial Ovarian Cancer. Cancer Management and Research, 14, 2803-2812. [Google Scholar] [CrossRef]
|
|
[23]
|
Tsai, Y.T., Ko, C.A., Chen, H.C., et al. (2022) Prognostic Value of CRP-Albumin-Lymphocyte (CALLY) Index in Patients Undergoing Surgery for Oral Cavity Cancer. Journal of Cancer, 13, 3000-3012. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
Liu, X.Y., Zhang, X., Zhang, Q., et al. (2023) The Value of CRP-Albumin-Lymphocyte Index (CALLY Index) as a Prognostic Biomarker in Patients with Non-Small Cell Lung Cancer. Support Care Cancer, 31, Article No. 533. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
Yang, M., Lin, S.Q., Liu, X.Y., et al. (2023) Association be-tween C-Reactive Protein-Albumin-Lymphocyte (CALLY) Index and Overall Survival in Patients with Colorectal Cancer: From the Investigation on Nutrition Status and Clinical Outcome of Common Cancers Study. Frontiers in Immunology, 14, Article ID: 1131496. [Google Scholar] [CrossRef] [PubMed]
|